PofoliaShared via Pofolia

Journal of Neuropathology & Experimental Neurology· 2026Q1

Comparison of the neural recovery effects of extracorporeal shockwave therapy according to administration time in sciatic nerve-injured rats

Yongsang Lee, Tae Heon Lee, Dongho Lee, Minsu Seo et al.

Short summary

Extracorporeal shockwave therapy (ESWT) initiated 7 days after sciatic nerve injury in rats yielded comparable nerve regeneration and functional recovery to immediate ESWT, suggesting delayed treatment is also effective.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Delayed ESWT (7 days post-injury) showed comparable neuroregenerative effects to immediate ESWT in a rat sciatic nerve crush model.
  • Both immediate and delayed ESWT increased expression of glial fibrillary acidic protein, S100β, BDNF, GAP-43, and NF200.
  • Histomorphometric analysis revealed similar improvements in axonal area and remyelination (G-ratio 0.59-0.60) for both treatment groups compared to controls (0.69).
  • Compound muscle action potential amplitudes at 9 weeks were significantly higher in both ESWT groups (39.5-40.1 mV) than in the control group (33.3 mV).

AI-generated from the title and abstract; the full text is not read.

Abstract

Abstract Extracorporeal shockwave therapy (ESWT) has been reported to promote peripheral nerve regeneration but whether its efficacy is maintained when treatment is initiated after the acute phase remains unclear. This study compared the neuroregenerative effects of immediate and delayed ESWT in a rat sciatic nerve crush model. Sixty rats were assigned to immediate treatment ([IT]; ESWT immediately after injury), delayed treatment ([DT]; ESWT 7 days postinjury), control, and sham groups. Extracorporeal shockwave therapy was delivered at an energy flux density of 0.19 mJ mm−². Molecular, structural, and functional outcomes were evaluated for 9 weeks. Both IT and DT groups showed higher expression of glial fibrillary acidic protein, S100β, brain-derived neurotrophic factor, growth-associated protein 43, and NF200 than the control group. Histomorphometric analysis showed comparable improvements in axonal area and remyelination. At 9 weeks, G-ratios were lower in the IT (0.59 ± 0.04) and DT (0.60 ± 0.02) groups than in the control group (0.69 ± 0.02; both P < .05), with no difference between the treatment groups. Compound muscle action potentials [CMAP] amplitudes at week 9 were higher in the IT (39.5 ± 2.6 mV) and DT (40.1 ± 3.0 mV) groups than the control group (33.3 ± 2.5 mV; both P < .05). Immediate and delayed ESWT were associated with improved nerve regeneration, supporting the biological efficacy of ESWT initiated 7 days postinjury in this sciatic nerve crush model.

The authors' abstract, as published at the source. Journal of Neuropathology & Experimental Neurology, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Cellular and Molecular Neuroscience

Cellular and Molecular NeuroscienceNeuroscience